GlassScriptPhysician profile
Michael Meghpara
NPI 1518428754
$21,159.30
in general payments reported to CMS, 2019-2025
7 companies · $8,730 in 2025
The $8,730 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,737 · 2022: $1,200 · 2023: $80.96 · 2024: $7,411 · 2025: $8,730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $7,000 · Travel and Lodging: $4,821 · Food and Beverage: $4,402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $7,000.00 |
| Travel and Lodging | $4,820.92 |
| Food and Beverage | $4,401.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $7,446.50 | 2024-2025 | Persona, Avenir, Rosa |
| Smith+Nephew, INC. | $7,424.91 | 2024-2025 | Real Intelligence, Redapt, R3 Acetabular |
| Liberty Surgical INC. | $3,600.00 | 2021 | |
| Paladin Technology Solutions | $1,200.00 | 2022 | |
| Stryker Corporation | $1,181.60 | 2023-2025 | Mako, 1788, Capri Corpectomy Cage System |
| Davol INC. | $280.38 | 2021-2024 | Arista Ah Flexitip |
| Ethicon US, LLC | $25.91 | 2024 | Ethicon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Meghpara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.